Frequently Asked Questions
The market is segmented based on , By Treatment (Hormonal Treatment and Non-Hormonal Treatment), Diagnosis (Physical Exam, Ultrasound, Blood Test), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Hot Flashes Treatment Market size was valued at USD 12.20 USD Billion in 2022.
The Global Hot Flashes Treatment Market is projected to grow at a CAGR of 7% during the forecast period of 2023 to 2030.
The major players operating in the market include AbbVie , Bausch Health Companies , Teva Pharmaceutical Industries Ltd, Cipla , Lupin, Sun Pharmaceuticals Industries Ltd, Hikma Pharmaceuticals PLC, Boehringer Ingelheim International GmbH, Sanofi, AstraZeneca, GSK Plc, Pfizer , Novartis AG, Mylan N.V, Hisamitsu Pharmaceutical Co , Merck & Co , TherapeuticsMD , Lilly, Emcure Pharmaceuticals Limited, Bayer AG.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
